WEHI-539 HCl |
2070018-33-4 |
2070018-33-4 |
BPR1M97 |
BPR1M97 |
2059904-66-2 |
JNJ-61432059 |
JNJ-61432059 |
2035814-50-5 |
AVN-944 |
化合物AVN944 |
297730-17-7 |
Leu-AMS |
288591-93-5 |
288591-93-5 |
AEOL-10150 |
286475-30-7 |
286475-30-7 |
CP-547632 |
3-[(4-溴-2,6-二氟苄基)氧基]-5-[3-[4-(吡咯烷-1-基)丁基]脲基]异噻唑-4-甲酰胺 |
252003-65-9 |
Linaprazan |
利那拉生 |
248919-64-4 |
N-[2-[[(3R)-1-[(4-chlorophenyl)methyl]-3-pyrrolidinyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamidehydrochloride |
226226-39-7 |
226226-39-7 |
3-(tetradecylcarbamoylamino)-4-trimethylammonio-butanoate |
TEGLICAR |
250694-07-6 |
OC 144-093 |
OC144-093; OC-144-093 |
216227-54-2 |
1-(6-chloro-5-(trifluoromethyl)pyridin-2-yl)piperazine hydrochloride |
1-(6-chloro-5-(trifluoromethyl)pyridin-2-yl)piperazine hydrochloride |
210821-63-9 |
6-B-HYDROXY EPLERENONE |
依普利酮6-BETA-羟基类似物 |
209253-80-5 |
BI 689648 |
1633009-87-6 |
1633009-87-6 |
SBC110,736 |
1629166-02-4 |
1629166-02-4 |
PB-22 N-pentanoic acid-3-carboxyindole metabolite |
PB-22 N-pentanoic acid-3-carboxyindole metabolite |
1630022-95-5 |
Peptide T TFA |
1610056-01-3 |
1610056-01-3 |
1-(4-(tert-butyl)benzyl)-3-(4-chlorophenyl)-N-hydroxy-1H-pyrazole-5-carboxamide |
1-(4-(tert-butyl)benzyl)-3-(4-chlorophenyl)-N-hydroxy-1H-pyrazole-5-carboxamide |
1610022-76-8 |
(rac)-5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{4-[(S-methylsulfonimidoyl)methyl]pyridin-2-yl}pyridin-2-amine |
(-)-BAY-1251152 |
1610358-59-2 |
VT-464 |
CS-1247 |
1610537-15-9 |